Year |
Citation |
Score |
2023 |
Signal B, Pérez Suárez TG, Taberlay PC, Woodhouse A. Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease. Neurobiology of Disease. 186: 106284. PMID 37683959 DOI: 10.1016/j.nbd.2023.106284 |
0.389 |
|
2021 |
Hogg SJ, Motorna O, Cluse LA, Johanson TM, Coughlan HD, Raviram R, Myers RM, Costacurta M, Todorovski I, Pijpers L, Bjelosevic S, Williams T, Huskins SN, Kearney CJ, Devlin JR, ... ... Taberlay PC, et al. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. Molecular Cell. 81: 2183-2200.e13. PMID 34019788 DOI: 10.1016/j.molcel.2021.04.015 |
0.407 |
|
2021 |
Giles KA, Gould CM, Achinger-Kawecka J, Page SG, Kafer GR, Rogers S, Luu PL, Cesare AJ, Clark SJ, Taberlay PC. BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer. Clinical Epigenetics. 13: 37. PMID 33596994 DOI: 10.1186/s13148-021-01023-7 |
0.341 |
|
2020 |
Khoury A, Achinger-Kawecka J, Bert SA, Smith GC, French HJ, Luu PL, Peters TJ, Du Q, Parry AJ, Valdes-Mora F, Taberlay PC, Stirzaker C, Statham AL, Clark SJ. Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains. Nature Communications. 11: 54. PMID 31911579 DOI: 10.1038/S41467-019-13753-7 |
0.46 |
|
2019 |
Skvortsova K, Stirzaker C, Taberlay P. The DNA methylation landscape in cancer. Essays in Biochemistry. 63: 797-811. PMID 31845735 DOI: 10.1042/Ebc20190037 |
0.504 |
|
2019 |
Sutton LP, Jeffreys SA, Phillips JL, Taberlay PC, Holloway AF, Ambrose M, Joo JE, Young A, Berry R, Skala M, Brettingham-Moore KH. DNA methylation changes following DNA damage in prostate cancer cells. Epigenetics. 1-14. PMID 31208284 DOI: 10.1080/15592294.2019.1629231 |
0.45 |
|
2019 |
Dyer M, Phipps AJ, Mitew S, Taberlay PC, Woodhouse A. Age, but Not Amyloidosis, Induced Changes in Global Levels of Histone Modifications in Susceptible and Disease-Resistant Neurons in Alzheimer's Disease Model Mice. Frontiers in Aging Neuroscience. 11: 68. PMID 31001106 DOI: 10.3389/Fnagi.2019.00068 |
0.362 |
|
2019 |
Giles KA, Gould CM, Du Q, Skvortsova K, Song JZ, Maddugoda MP, Achinger-Kawecka J, Stirzaker C, Clark SJ, Taberlay PC. Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups. Epigenetics & Chromatin. 12: 12. PMID 30755246 DOI: 10.1186/S13072-019-0258-9 |
0.431 |
|
2017 |
Phillips JL, Taberlay PC, Woodworth AM, Hardy K, Brettingham-Moore KH, Dickinson JL, Holloway AF. Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells. Journal of Cellular Physiology. PMID 28926098 DOI: 10.1002/Jcp.26197 |
0.422 |
|
2017 |
Achinger-Kawecka J, Taberlay PC, Clark SJ. Alterations in Three-Dimensional Organization of the Cancer Genome and Epigenome. Cold Spring Harbor Symposia On Quantitative Biology. PMID 28424341 DOI: 10.1101/Sqb.2016.81.031013 |
0.531 |
|
2016 |
Phipps AJ, Vickers JC, Taberlay PC, Woodhouse A. Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease. Neurobiology of Aging. 45: 30-42. PMID 27459923 DOI: 10.1016/J.Neurobiolaging.2016.05.003 |
0.36 |
|
2016 |
Taberlay PC, Achinger-Kawecka J, Lun AT, Buske FA, Sabir K, Gould CM, Zotenko E, Bert SA, Giles KA, Bauer DC, Smyth GK, Stirzaker C, O'Donoghue SI, Clark S. Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations. Genome Research. PMID 27053337 DOI: 10.1101/Gr.201517.115 |
0.498 |
|
2015 |
Statham AL, Taberlay PC, Kelly TK, Jones PA, Clark SJ. Genome-wide nucleosome occupancy and DNA methylation profiling of four human cell lines. Genomics Data. 3: 94-6. PMID 26484155 DOI: 10.1016/J.Gdata.2014.11.012 |
0.571 |
|
2015 |
Brettingham-Moore KH, Taberlay PC, Holloway AF. Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia. Frontiers in Immunology. 6: 499. PMID 26483790 DOI: 10.3389/fimmu.2015.00499 |
0.448 |
|
2015 |
Qadi AA, Taberlay PC, Phillips JL, Young A, West AC, Brettingham-Moore KH, Dickinson JL, Holloway AF. The Leukemia Inhibitory Factor Receptor gene is a direct target of RUNX1. Journal of Cellular Biochemistry. PMID 26060100 DOI: 10.1002/Jcb.25246 |
0.431 |
|
2015 |
Brettingham-Moore KH, Taberlay PC, Holloway AF. Interplay between transcription factors and the epigenome: Insight from the role of RUNX1 in leukemia Frontiers in Immunology. 6. DOI: 10.3389/Fimmu.2015.00499 |
0.49 |
|
2015 |
Statham AL, Taberlay PC, Kelly TK, Jones PA, Clark SJ. Genome-wide nucleosome occupancy and DNA methylation profiling of four human cell lines Genomics Data. 3: 94-96. DOI: 10.1016/j.gdata.2014.11.012 |
0.413 |
|
2014 |
Skulte KA, Phan L, Clark SJ, Taberlay PC. Chromatin remodeler mutations in human cancers: epigenetic implications. Epigenomics. 6: 397-414. PMID 25333849 DOI: 10.2217/Epi.14.37 |
0.55 |
|
2014 |
Taberlay PC, Statham AL, Kelly TK, Clark SJ, Jones PA. Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer. Genome Research. 24: 1421-32. PMID 24916973 DOI: 10.1101/Gr.163485.113 |
0.576 |
|
2014 |
Stirzaker C, Taberlay PC, Statham AL, Clark SJ. Mining cancer methylomes: prospects and challenges. Trends in Genetics : Tig. 30: 75-84. PMID 24368016 DOI: 10.1016/J.Tig.2013.11.004 |
0.403 |
|
2012 |
De Carvalho DD, Sharma S, You JS, Su SF, Taberlay PC, Kelly TK, Yang X, Liang G, Jones PA. DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell. 21: 655-67. PMID 22624715 DOI: 10.1016/J.Ccr.2012.03.045 |
0.552 |
|
2011 |
Taberlay PC, Kelly TK, Liu CC, You JS, De Carvalho DD, Miranda TB, Zhou XJ, Liang G, Jones PA. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell. 147: 1283-94. PMID 22153073 DOI: 10.1016/J.Cell.2011.10.040 |
0.488 |
|
2011 |
You JS, Kelly TK, De Carvalho DD, Taberlay PC, Liang G, Jones PA. OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proceedings of the National Academy of Sciences of the United States of America. 108: 14497-502. PMID 21844352 DOI: 10.1073/Pnas.1111309108 |
0.553 |
|
2011 |
Taberlay PC, Jones PA. DNA methylation and cancer. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrã¨S Des Recherches Pharmaceutiques. 67: 1-23. PMID 21141722 DOI: 10.1007/978-3-7643-8989-5_1 |
0.593 |
|
Show low-probability matches. |